| Toggle Summary
|
Osiris Provides Update Regarding NASDAQ Listing Matters
|
View HTML
|
| Toggle Summary
|
Grafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal
|
View HTML
|
| Toggle Summary
|
Osiris Provides Update Regarding NASDAQ Listing Matters
|
View HTML
|
| Toggle Summary
|
Osiris to Present at the 26th European Wound Management Association Conference
|
View HTML
|
| Toggle Summary
|
Grafix Demonstrates Superior Clinical Outcomes Compared with EpiFix in "Real World" Study
|
View HTML
|
| Toggle Summary
|
Osiris to Present 15 Advanced Clinical and Scientific Abstracts
|
View HTML
|
| Toggle Summary
|
Osiris Announces Further Expansion of Grafix Commercial Coverage
|
View HTML
|
| Toggle Summary
|
Osiris Therapeutics Announces Receipt of Deficiency Letter from NASDAQ
|
View HTML
|
| Toggle Summary
|
Osiris Therapeutics to Present at the 4th Annual Cell and Gene Therapy Investor Day
|
View HTML
|
| Toggle Summary
|
Osiris Provides an Update on a Clinical Review by Blue Cross Blue Shield Association
|
View HTML
|
